RPA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.439900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.399600E-01
Normal-vs-Stage2
5.142300E-02
Normal-vs-Stage3
4.241700E-02
Normal-vs-Stage4
1.645600E-01
Stage1-vs-Stage2
9.034600E-01
Stage1-vs-Stage3
1.705200E-01
Stage1-vs-Stage4
8.803400E-01
Stage2-vs-Stage3
1.934560E-01
Stage2-vs-Stage4
8.117600E-01
Stage3-vs-Stage4
7.522300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.146100E-02
Normal-vs-AfricanAmerican
2.078400E-01
Normal-vs-Asian
1.547760E-02
Caucasian-vs-AfricanAmerican
3.740600E-01
Caucasian-vs-Asian
1.319850E-01
AfricanAmerican-vs-Asian
3.095900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.119700E-02
Normal-vs-Female
1.300650E-01
Male-vs-Female
1.625950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.601390E-01
Normal-vs-Age(41-60Yrs)
2.340000E-01
Normal-vs-Age(61-80Yrs)
2.336400E-02
Normal-vs-Age(81-100Yrs)
3.233600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.067800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.946200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.685200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.580500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.233160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.278200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.291520E-02
Normal-vs-Daily Drinker
5.039400E-03
Normal-vs-Weekly Drinker
3.778800E-01
Normal-vs-Occasional Drinker
3.681800E-01
Normal-vs-Social Drinker
1.297950E-01
Non Drinker-vs-Daily Drinker
4.903800E-01
Non Drinker-vs-Weekly Drinker
5.024600E-01
Non Drinker-vs-Occasional Drinker
3.502300E-02
Non Drinker-vs-Social Drinker
1.264620E-01
Daily Drinker-vs-Weekly Drinker
3.391200E-01
Daily Drinker-vs-Occasional Drinker
2.256100E-02
Daily Drinker-vs-Social Drinker
4.107700E-02
Weekly Drinker-vs-Occasional Drinker
5.814200E-01
Weekly Drinker-vs-Social Drinker
9.001400E-01
Occasional Drinker-vs-Social Drinker
5.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.642600E-01
Normal-vs-Grade 2
7.407200E-01
Normal-vs-Grade 3
7.500600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.271400E-01
Grade 1-vs-Grade 3
6.479400E-01
Grade 1-vs-Grade 4
7.642600E-01
Grade 2-vs-Grade 3
6.470600E-01
Grade 2-vs-Grade 4
7.407200E-01
Grade 3-vs-Grade 4
7.500600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.075600E-02
Normal-vs-NonDiabetic
5.979800E-02
Diabetic-vs-NonDiabetic
4.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.941800E-02
Normal-vs-NoPancreatitis
5.299700E-02
Pancreatitis-vs-NoPancreatitis
9.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.012960E-01
Normal-vs-N1
5.023600E-02
N0-vs-N1
3.088800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.962400E-02
Normal-vs-TP53-NonMutant
1.814580E-01
TP53-Mutant-vs-TP53-NonMutant
1.286360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
